Immunogenicity of hepatitis B vaccine incorporated into the expanded program of immunization schedule

Indian Pediatrics

Volumn 37, Issue 4, 2000, Pages 411-413

  Gomber, Sunil ^a,b   Sharma, Rajesh ^a   Ramachandran, V G ^a   Talwar, Vibha ^a   Singh, Bharat ^a  

^a UNIVERSITY COLLEGE OF MEDICAL SCIENCES   (India)

^b F 4A ^*  (India)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B VACCINE;

ANTIBODY TITER; ARTICLE; CHILD; CLINICAL TRIAL; ENZYME LINKED IMMUNOSORBENT ASSAY; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; IMMUNIZATION; INFANT; MAJOR CLINICAL STUDY; TREATMENT OUTCOME; VACCINATION; VIRUS HEPATITIS;

DIPHTHERIA-TETANUS-PERTUSSIS VACCINE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS B; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VACCINES; HUMANS; IMMUNIZATION PROGRAMS; IMMUNIZATION SCHEDULE; INFANT; INJECTIONS, INTRAMUSCULAR; MALE; POLIOVIRUS VACCINE, ORAL; SENSITIVITY AND SPECIFICITY;

EID: 0034055709     PISSN: 00196061     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Kane M. Global Program for control of hepatitis B infection. Vaccine 1995; 13: S47-S49.
2. Nayak NC, Panda SK, Zuckerman AJ, Bhan MK, Guba DK. Dynamics and impact of perinatal transmission of Hepatitis B virus in North India. J Med Virol 1987; 21: 137-145.
3. World Health Organization. Immunization Policy WHO/EPI/GEN/95.3, 1995.
4. John TJ. Hepatitis B immunization. Indian Pediatr 1995; 32: 609-613.
5. Brunell PA. Hepatitis. In: Nelson Textbook of Pediatrics, 14th edn. Eds. Behrman RE, Kleigman RM, Nelson WE, Vaughan VC III. Philadelphia, W.B. Saunders Co., 1992; pp 818-822.
6. Greenberg DP, Vadheim CM, Marcy SM, Partridge S, Jing J, Chiu CY, et al. Safety and immunogenicity of a recombinant hepatitis B vaccine administered to infants at 2, 4 and 6 months of age. Vaccine 1996; 14: 811-816.
7. Canvo RD, Grosheide PM, Voogd M, Huisman WM, Heijtink RA, Schalm SW. Immunogenicity of 20 μg of recombinant DNA hepatitis B vaccine in healthy neonates: A comparison of three different vaccination schemes. J Med Virol 1993; 41: 30-34.
8. Mittal SK, Rao S, Kumar S, Aggarwal V, Prakash C, Thiruparam S. Simultaneous administration of hepatitis B vaccine with other EPI vaccines. Indian J Pediatr 1994; 61: 183-188.
9. VillaGD, Picciotto L, Ribera G, Bencivenga M, Cotugno M, Hartmann P. Effective antibody response in newborn babies living in Maldives to simultaneous vaccination against hepatitis B, poliomyelitis, diphtheria and tetanus. Vaccine 1995; 13: 795-798.
10. Coursaget P, Yvonnet B, Relyveld EH, Barres JL, Dipo-Mar I, Chiron JP. Simultaneous administration of Diphtheria-Texanus-Pertussis-Polio and Hepatitis B vaccines in a simplified immunization program. Infection and Immunity 1985; 51: 784-787.
11. Giammanco G, Moiraghi A, Zotti C, Pignato S, Volti Li S, Giammanco A, et al. Safety and immunogenicity of a combined diphteria-tetanus-acellular pertusis-hepatitis B vaccine administered according to two different primary vaccination schedules. Vaccine 1998; 16: 722-726.
12. Safary A. Hepatitis B vaccination - Now and in the future. In: Hepatitis-B in India: Problems and Prevention. Eds, Sarin SK, Singhal AK. New Delhi, CBS Publishers, 1996; pp 132-151.
13. Coberly JS, Townsend T, Repke J, Fields H, Margolis H, Halsey NA. Suboptimal response following intradermal hepatitis B vaccine in infants. Vaccine 1994; 12: 984-987.
14. Stevens CE, Toy PT, Taylor PE, Lee T, YipH. Prospects for control of hepatitis B virus infection: Implications of childhood vaccination and longterm protection. Pediatrics 1992; 90: 170-173.